The first data on Paxlovid, out last November, hinted that the COVID antiviral would cut the risk of hospitalization and death by 89 percent. Pundits called...
Conversely, if some of these vaccine candidates prove to be ineffective, it should not be a shock. The development process from Phase I to II and...
Recent Comments